Xiaojin Yin

542 total citations
20 papers, 437 citations indexed

About

Xiaojin Yin is a scholar working on Molecular Biology, Cancer Research and Biomaterials. According to data from OpenAlex, Xiaojin Yin has authored 20 papers receiving a total of 437 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 6 papers in Cancer Research and 4 papers in Biomaterials. Recurrent topics in Xiaojin Yin's work include Angiogenesis and VEGF in Cancer (9 papers), Cancer, Hypoxia, and Metabolism (4 papers) and Hepatocellular Carcinoma Treatment and Prognosis (3 papers). Xiaojin Yin is often cited by papers focused on Angiogenesis and VEGF in Cancer (9 papers), Cancer, Hypoxia, and Metabolism (4 papers) and Hepatocellular Carcinoma Treatment and Prognosis (3 papers). Xiaojin Yin collaborates with scholars based in China. Xiaojin Yin's co-authors include Raphael N. Alolga, Shi-Lei Wang, Lian‐Wen Qi, Ling Li, Jianping Zhou, Yali Chen, Shuaiwen Tang, Jinhui Wu, Yiqiao Hu and Leilei Chang and has published in prestigious journals such as Food Chemistry, Journal of Controlled Release and International Journal of Pharmaceutics.

In The Last Decade

Xiaojin Yin

20 papers receiving 426 citations

Peers

Countries citing papers authored by Xiaojin Yin

Since Specialization

Citations

This map shows the geographic impact of Xiaojin Yin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaojin Yin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaojin Yin more than expected).

Fields of papers citing papers by Xiaojin Yin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaojin Yin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaojin Yin. The network helps show where Xiaojin Yin may publish in the future.

Co-authorship network of co-authors of Xiaojin Yin

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaojin Yin. A scholar is included among the top collaborators of Xiaojin Yin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaojin Yin. Xiaojin Yin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Capture of Rayleigh particles by focused double-ring perfect vortex beams 2025 ·Acta Physica Sinica ·(unknown), Yang Chen, Xiaojin Yin, Jie Wang	1
2	Interpretable hierarchical belief rule base expert system for complex system modeling 2023 ·Measurement ·You Cao, Shuaiwen Tang, (unknown), Leilei Chang, Xiaojin Yin	26
3	[Research on Self-perception and Active Warning Model of Medical Equipment Operation and Maintenance Status Based on Machine Learning Algorithm]. 2021 ·PubMed ·Yuchun Ma, (unknown), Xiaojin Yin	4
4	A comparative UPLC-Q/TOF-MS-based metabolomics approach for distinguishing Zingiber officinale Roscoe of two geographical origins 2017 ·Food Chemistry ·(unknown), Raphael N. Alolga, Shi-Lei Wang, (unknown), Xiaojin Yin, Lian‐Wen Qi	88
5	Molecular targeting of VEGF/VEGFR signaling by the anti-VEGF monoclonal antibody BD0801 inhibits the growth and induces apoptosis of human hepatocellular carcinoma cells in vitro and in vivo 2017 ·Cancer Biology & Therapy ·Lin Liu, Shukui Qin, Yinghui Zheng, Li Han, Minmin Zhang, (unknown), (unknown), Ning Gu, (unknown), Xiaojin Yin	31
6	Endostar inhibits ascites formation and prolongs survival in mouse models of malignant ascites 2015 ·Oncology Letters ·Hongmei Wei, Shukui Qin, Xiaojin Yin, Yali Chen, Haiqing Hua, Lin Wang, (unknown), (unknown), (unknown)	7
7	Hepatitis B surface antigen (HBsAg) and core antigen (HBcAg) combine CpG oligodeoxynucletides as a novel therapeutic vaccine for chronic hepatitis B infection 2015 ·Vaccine ·Jianqiang Li, Junwei Ge, (unknown), (unknown), Ying Sun, (unknown), Yue Gu, Hongying Huang, Zhenxing Xu, Xiaoxiao Chen, Xiaowei Xu, (unknown), (unknown), (unknown), Aiguo Xu, Xiaojin Yin, (unknown)	30
8	Inhibitory Effect of Endostar on Specific Angiogenesis Induced by Human Hepatocellular Carcinoma 2015 ·Gastroenterology Research and Practice ·Qing Ye, Shukui Qin, Yanhong Liu, (unknown), Qiong Wu, (unknown), Xiaojin Yin	6
9	Synergistic effects of Endostar combined with β-elemene on malignant ascites in a mouse model 2012 ·Experimental and Therapeutic Medicine ·Ziyu Jiang, Shukui Qin, Xiaojin Yin, Yali Chen, Lin Zhu	18
10	Recombinant human CD137L for cancer immunotherapy: effects of different fusions and linkers on its activity 2011 ·Cancer Immunology Immunotherapy ·Shuzhen Wang, (unknown), Peng Wang, Xiaojin Yin, (unknown), Yijun Chen	5
11	Soluble expression of recombinant human CD137 ligand in Escherichia coli by co-expression of chaperones 2011 ·Journal of Industrial Microbiology & Biotechnology ·Shuzhen Wang, (unknown), (unknown), Peng Wang, Xiaojin Yin, Yijun Chen	8
12	Effect of medium-chain triglycerides on the release behavior of Endostar® encapsulated PLGA microspheres 2010 ·International Journal of Pharmaceutics ·(unknown), Ling Li, Hua Su, Qingsong Wang, Chunhui Liu, (unknown), Xiaojin Yin	7
13	[Therapeutic features of endostar, a modified endostatin, on ascites tumor in mice]. 2010 ·PubMed ·Hongmei Wei, Shukui Qin, Xiaojin Yin, Yali Chen	5
14	Characterization of a monoPEG20000-Endostar 2010 ·International Journal of Biological Macromolecules ·Tong Yue, Kai Zhong, Hong Tian, Xiangdong Gao, Xiangyang Xu, Xiaojin Yin, Wenbing Yao	26
15	Constitutive Models for Reinforcing Steel Bars under High Strain Rates 2008 ·Journal of Building Materials ·Xiaojin Yin	16
16	Microspheres made by w/o/o emulsion method with reduced initial burst for long-term delivery of endostar, a novel recombinant human endostatin 2008 ·Journal of Pharmaceutical Sciences ·Jinhui Wu, Lin Wu, Xiaoqiang Xu, (unknown), Xiaojin Yin, Ying‐Jie Chen, Yiqiao Hu	19
17	Sustained delivery of endostatin improves the efficacy of therapy in Lewis lung cancer model 2008 ·Journal of Controlled Release ·Jinhui Wu, (unknown), Guoyan Ren, (unknown), Xiaojin Yin, Yiqiao Hu	15
18	Doxycycline Influences Microcirculation Patterns in B16 Melanoma 2007 ·Experimental Biology and Medicine ·Baocun Sun, Shiwu Zhang, Danfang Zhang, Xiaojin Yin, Sen Wang, Yanjun Gu, Yalei Wang	26
19	Preparation and characterization of N-succinyl-N′-octyl chitosan micelles as doxorubicin carriers for effective anti-tumor activity 2006 ·Colloids and Surfaces B Biointerfaces ·(unknown), Ling Li, Jianping Zhou, (unknown), (unknown), Xiaojin Yin, (unknown)	98
20	Study of Contact Thermal Resistance Between Two Coaxial Cylindrical Layers(I):Mathematical Model 1996 ·Journal of University of Science and Technology Beijing ·Xiaojin Yin	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact